AI assistant
Sending…
LB PHARMACEUTICALS INC — Director's Dealing 2025
Sep 13, 2025
33183_dirs_2025-09-12_b67a01e6-2518-4532-a789-5c99f5b9ca5e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LB PHARMACEUTICALS INC (LBRX)
CIK: 0001691082
Period of Report: 2025-09-10
Reporting Person: Nussbaum Ran (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-09-10 | Stock Option (Right to Buy) | $15 | A | 22449 | Acquired | 2035-09-09 | Common Stock (22449) | Direct |
Footnotes
F1: The option award shall vest in three (3) equal annual installments on September 10, 2026, September 10, 2027 and September 10, 2028, subject to the Reporting Person's continuous service through such vesting date.
More from LB PHARMACEUTICALS INC
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Mar 26
Major Shareholding Notification
2026
Feb 10
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 5